Review ArticleActions of “antioxidants” in the protection against atherosclerosis
Graphical abstract
Highlights
► Arterial lipid/protein oxidation occurs during and is thought to cause atherogenesis. ► Vitamin E, however, does not generally attenuate atherosclerosis or reduce CVD. ► Arterial lipoprotein oxidation can be dissociated from atherosclerosis. ► Antioxidants inhibit atherosclerosis by means other than oxidant scavenging. ► Burden of proof needs to shift to proving that oxidative damage causes atherosclerosis.
Introduction
Cardiovascular disease (CVD) remains the major cause of mortality in the world, typically claiming a third of all deaths. The primary cause of CVD is atherosclerosis, which literally refers to the hardening of arteries. In atherosclerosis, medium to large arteries are affected and hardening is caused by the buildup of waste products, such as lipids including cholesterol, cellular debris, and calcium in the affected artery wall. Together these substances form plaque, which, when large enough, can restrict blood flow or, upon rupture, can give rise to a blood clot with the risk of a heart attack.
Atherosclerosis is a disease that progresses slowly during a lifetime and typically begins before adulthood. This slow disease progression and complex etiology have challenged attempts to identify the initial atherogenic event such that it remains elusive. The healthy artery consists of three distinct layers [1]. The innermost layer facing the arterial lumen consists of a monolayer of endothelial cells, followed by the inner elastic lamina. On the peripheral side of the inner elastic lamina reside layers of vascular smooth muscle cells (VSMC) that make up the media, bordered by the outer elastic lamina. The outer layer of the artery, the adventitia, consists of connective tissue.
The vascular endothelium is the barrier between the blood and the arterial vessel wall. One of the first clinically detectable changes in the vasculature during atherogenesis is a dysfunctional endothelium (reviewed in [2]). This is characterized by a decreased response to endothelium-dependent relaxation and has been reported for human arteries with atherosclerotic lesions [3] as well as for arterial segments isolated from animal models of atherosclerosis. A dysfunctional endothelium promotes many processes involved in atherogenesis [2]. These include decreased bioavailability of nitric oxide (•NO) and VSMC migration and proliferation that can contribute to the formation of a neointima between the endothelium and the inner elastic lamina [1]. A key process commonly thought to be involved in endothelial dysfunction is the “uncoupling” of endothelial nitric oxide synthase (eNOS), a term used to describe the change in function of the synthase from an •NO- to a superoxide anion radical (O2•−)-producing enzyme [4], [5], [6]. Oxidative processes can contribute to the uncoupling of eNOS [7], although the relevance of this to endothelial dysfunction in vivo remains largely unknown.
Atherosclerotic lesions occur preferentially at regions exposed to disturbed blood flow, such as branch points and curvatures of arteries. The disturbed blood flow allows the endothelial cells that line the blood vessel to adopt a proinflammatory phenotype, and this generates arterial regions of higher permeability toward macromolecules [1], [8]. These facilitate the entry of lipoproteins, including low-density lipoprotein (LDL), into the arterial wall. This results in the accumulation of lipid, primarily cholesterol as well as polar, oxidized fatty acids [9], [10], and contributes to arterial inflammation [11], [12]. The initial lipid deposits have long been thought to consist of LDL retained in the intima that becomes internalized by macrophages [1] and thereby leads to foam cell formation and intimal cell proliferation. However, recent studies suggest that in the normal murine aortic intima, dendritic cells preferentially reside in areas predisposed to lesion formation [13] and that dendritic cells are important in the development of foam cells and early atherogenesis [14].
To characterize the initiating cause of atherosclerosis, three different but somewhat overlapping hypotheses have been proposed. Thus, the initiating event in atherosclerosis is considered to be a response to injury/inflammation, LDL retention, or the oxidative modification of LDL. These hypotheses overlap in that they all invoke LDL retention and modification in the intima as a key event (reviewed in [2]).
In the response-to-injury hypothesis, endothelial dysfunction is a key event. Initially it was thought that injury to the endothelium simply leads to increased permeability and hence passive deposition of LDL lipid in the subendothelial space. Subsequently, an active inflammatory response was invoked to contribute to endothelial cell injury and to drive lipid accumulation and alter arterial homeostasis [11], [12]. However, as atherosclerotic lesions can occur underneath a physically intact endothelium, the hypothesis has been refined to include the uncontrolled entry of atherogenic (i.e., altered) lipoproteins by dysfunctional endothelial cells.
Circulating lipoproteins move through the arterial wall in accordance with their molecular size. In rabbits, injection of human LDL results in lipoprotein aggregates within the arterial wall [15], a key observation based on which the response-to-retention hypothesis was formulated [16], [17]. Accordingly, proteoglycans in the arterial wall matrix retain extracellular lipoproteins containing apolipoprotein B-100 for subsequent cellular uptake [18]. In support of this theory, genetic manipulations aimed at interrupting the interaction between apolipoprotein B-100 and proteoglycans decrease atherosclerosis in animals [19], [20].
The basis of the oxidative modification hypothesis is the discovery by Brown et al. that chemically modified LDL is taken up by macrophage scavenger receptors at a 20-fold higher rate than native LDL [21]. Steinberg and co-workers proposed that “oxidation renders a chemical modification to LDL that increases its atherogenicity” [22]. Accordingly, LDL in the intima is subject to cell-induced oxidation that modifies the lipoprotein such that it is prevented from leaving the arterial wall and instead induces further lipid accumulation, endothelium dysfunction, and inflammation. Indeed, the presence of oxidized lipids in atherosclerotic lesions has been known for at least 40 years [23], and it has since been confirmed and extended to proteins in numerous studies. It is also clear that LDL oxidized in vitro by various means can lead to foam cell formation [24], [25], [26]. As reviewed previously, such “oxidized LDL” has a myriad of potential atherogenic properties (see e.g., [2], [22], [27], [28], [29], [30]). Of concern, however, “oxidized LDL” and “oxidatively modified LDL” are terms that do not refer to chemically defined entities [31], such that the meaning of studies employing in vitro-generated oxidized LDL remains unclear. Based on functional rather than chemical properties, a broad distinction has been made by some between “minimally modified LDL” (i.e., LDL still recognized by the LDL receptor) and “extensively/fully oxidized LDL” (i.e., oxLDL, recognized by scavenger receptors) [32]. However, the meaningfulness of this functional distinction can be argued, as lesion LDL is taken up avidly by macrophages independent of scavenger receptors [33]. Thus, despite more than 20 years of intense research, clear evidence for how, where, and when LDL is oxidized in the intima during atherogenesis, and to what extent this contributes directly to the initiation of atherosclerosis, remains largely unknown (Table 1).
Steinberg recently extended the original oxidative modification hypothesis by proposing that oxidative stress independent of, or accompanied by, LDL oxidation may contribute to atherogenesis [30]. Indeed, current research now more broadly examines how increased oxidative stress and oxidative events may participate in arterial pathology and how antioxidants may be involved in or regulate these processes. This review focuses on oxidative events, antioxidants, and their molecular and cellular effects in the context of atherosclerosis.
Section snippets
Oxidative damage in atherosclerosis
Our understanding of redox reactions in the vasculature is based principally on the description of intra- and extracellular markers of oxidative stress and damage, as well as enzymatic and nonenzymatic sources of both endogenous oxidants and antioxidants. Oxidative damage is commonly viewed as a consequence of oxidative stress that itself is defined classically as the tipping of the balance of pro- and antioxidant events in favor of the former. However, the concept of pro- versus antioxidant
Redox-regulated processes in atherosclerosis
As radical or 1e oxidants readily oxidize lipids, including those of LDL, they have been proposed as pertinent oxidants in atherosclerosis. In addition, nonradical oxidants that preferentially react with proteins are also thought to be important contributors to oxidative damage in atherosclerotic arteries [2]. Although viewed originally as only damaging, reactive oxygen and nitrogen species are now also recognized as being important in the regulation of a number of physiological and
Antioxidant strategies in experimental atherosclerosis
Antioxidants are substances that protect against oxidative damage even when present in significantly smaller amounts than the target molecule [51]. The oxidative hypothesis of atherosclerosis implies a protective role of antioxidants because it envisages adverse events occurring when antioxidant defenses are overwhelmed [22], [30], [52]. As the occurrence of oxidative stress is difficult to assess in vivo, indirect measures such as changes in the content or expression of specific antioxidants,
Endogenous nonenzymatic antioxidants
Nonproteinaceous antioxidants are usually of low molecular weight and present within and/or outside cells in a lipid or aqueous environment. Some of the nonproteinaceous antioxidants, such as glutathione, are synthesized, whereas others, such as vitamins E and C, need to be provided through the diet. When nonproteinaceous antioxidants react with a radical oxidant an antioxidant-derived radical of lower reactivity is produced. This can result in the “compartmental transition” of the radical
Dietary antioxidants
Despite the existence of an extensive cellular antioxidant system, some (though not all) dietary antioxidants have also been shown to exert antiatherosclerotic effects (Table 2), although it is less clear whether the protective effects were the results of direct oxidant scavenging or indirect, via the induction of cellular antioxidants. The following discussion is limited to studies with isolated compounds, although we are aware of the increasing body of literature reporting on the effects of
Synthetic antioxidants: probucol and related phenols
The protective effects of probucol and probucol-related phenols on atherosclerosis and CVD have been reviewed recently [250], and therefore are discussed here only briefly, with a focus on mechanistic aspects. Historically, probucol was introduced in medical research as a cholesterol-lowering compound [251]. The drug then assumed a role as a supporting pillar of the oxidative modification hypothesis of atherosclerosis by studies demonstrating that inhibition of atherosclerosis by probucol both
Future directions
Despite unambiguous evidence for the presence of oxidative damage in atherosclerotic lesions, its importance as a general cause of and contributor to atherogenesis is challenged by the general lack of benefit from antioxidants in clinical studies. The oxidative modification hypothesis of atherosclerosis suggests that LDL oxidation initiates disease and that foam cell formation by oxidized LDL represents an early key event in atherogenesis. However, foam cells can arise from LDL modified in ways
Acknowledgments
M.E. Lönn acknowledges support from the Mats Kleberg Foundation. The work in R. Stocker's laboratory is supported by National Health & Medical Research Council of Australia (NH&MRC) Programme Grant 455395 and by grants from the Australian Research Council. R. Stocker also acknowledges the support he receives as a recipient of a NH&MRC Senior Principal Research Fellowship and a University of Sydney Professorial Fellowship.
References (307)
Atherosclerosis
Nature
(2000)- et al.
Role of oxidative modifications in atherosclerosis
Physiol. Rev.
(2004) - et al.
Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
N. Engl. J. Med.
(1986) - et al.
Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors
Proc. Natl. Acad. Sci. USA
(1998) - et al.
Superoxide generation from endothelial nitric-oxide synthase: a Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process
J. Biol. Chem.
(1998) - et al.
Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin
Circulation
(2001) - et al.
S-Glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling
Antioxid. Redox Signaling
(2011) - et al.
Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis
J. Vasc. Res.
(2009) - et al.
Lipids of human atheroma: isolation of hydroxyoctadecadienoic acids from advanced aortal lesions
Biochim. Biophys. Acta
(1970) - et al.
Lipids of human atheroma. Part 5. The occurrence of a new group of polar sterol esters in various stages of human atherosclerosis
Atherosclerosis
(1971)
The pathogenesis of atherosclerosis
N. Engl. J. Med.
The pathogenesis of atherosclerosis
N. Engl. J. Med.
Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis
J. Exp. Med.
Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis
Circ. Res.
Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein: a deep-etch and immunolocalization study of ultrarapidly frozen tissue
Arterioscler. Thromb
The response-to-retention hypothesis of early atherogenesis
Arterioscler. Thromb. Vasc. Biol.
The response-to-retention hypothesis of atherogenesis reinforced
Curr. Opin. Lipidol.
Complexes of low-density lipoproteins and arterial proteoglycan aggregates promote cholesteryl ester accumulation in mouse macrophages
Biochim. Biophys. Acta
Identification of the principal proteoglycan-binding site in LDL: a single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding
J. Clin. Invest.
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
Nature
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
Proc. Natl. Acad. Sci. USA
Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
N. Engl. J. Med.
Lipids in human atheroma. Part 4. Characterisation of a new group of polar sterol esters from human atherosclerotic plaques
Atherosclerosis
Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins
Proc. Natl. Acad. Sci. USA
Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
Proc. Natl. Acad. Sci. USA
Modification of human low density lipoprotein by oxidation—characterization and pathophysiological implications
Chem. Phys. Lipids
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
Free Radic. Biol. Med.
J. W. The role of oxidized lipoproteins in atherogenesis
Free Radic. Biol. Med.
The oxidative modification hypothesis of atherosclerosis
The LDL modification hypothesis of atherogenesis: an update
J. Lipid Res.
Oxidized low density lipoprotein—an extreme example of lipoprotein heterogeneity
Isr. J. Med. Sci.
Oxidized LDL: diversity, patterns of recognition, and pathophysiology
Antioxid. Redox Signaling
Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima
Arterioscler. Thromb
Redefining oxidative stress
Antioxid. Redox Signaling
Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects
Free Radic. Biol. Med
Beyond LDL oxidation: ROS in vascular signal transduction
Free Radic. Biol. Med.
Activation of tyrosine kinases by reactive oxygen species in vascular smooth muscle cells: significance and involvement of EGF receptor transactivation by angiotensin II
Antioxid. Redox Signaling
Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration
Circ. Res.
Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression
Circ. Res.
Requirement for generation of H2O2 for platelet-derived growth factor signal transduction
Science
Activated transcription nuclear factor-kappa B is present in atherosclerotic lesion
J. Clin. Invest.
Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress
Arterioscler. Thromb. Vasc. Biol.
Superoxide dismutases: role in redox signaling, vascular function, and diseases
Antioxid. Redox Signaling
Superoxide induces endothelial nitric-oxide synthase protein thiyl radical formation, a novel mechanism regulating eNOS function and coupling
J. Biol. Chem.
Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells
Cardiovasc. Res.
Phosphorylation and concomitant structural changes in human 2-Cys peroxiredoxin isotype I differentially regulate its peroxidase and molecular chaperone functions
FEBS Lett
Inactivation of peroxiredoxin I by phosphorylation allows localized H2O2 accumulation for cell signaling
Cell
Catalase activity is regulated by c-Abl and Arg in the oxidative stress response
J. Biol. Chem.
Glutathione peroxidase 1 is regulated by the c-Abl and Arg tyrosine kinases
J. Biol. Chem.
Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking
Proc. Natl. Acad. Sci. USA
Cited by (101)
Iron and atherosclerosis: Lessons learned from rabbits relevant to human disease
2023, Free Radical Biology and MedicineSyzygium cumini leaf extract protects macrophages against the oxidized LDL-induced toxicity: A promising atheroprotective effect
2021, Biomedicine and PharmacotherapyAntioxidant properties of anthocyanins and their mechanism of action in atherosclerosis
2021, Free Radical Biology and MedicineTwo compounds of the Colombian algae Hypnea musciformis prevent oxidative damage in human low density lipoproteins LDLs
2019, Journal of Functional FoodsCitation Excerpt :Extract concentrations were equivalent to 40 µM/L of alpha tocopherol (vitamin E). The lag phase for untreated LDLs may be associated with natural endogenous or enzymatic antioxidants or with those present in the diet (Lönn, Dennis, & Stocker, 2012; Mirończuk-Chodakowska, Witkowska, & Zujko, 2018; Yoshida & Kisugi, 2010). In this case, LDLs were protected for a time frame of 72 ± 6 min, after which rapid oxidation began.
Effects of Royal jelly on metabolic variables in diabetes mellitus: A systematic review
2019, Complementary Therapies in Medicine